Locations
United States · New York County, NY, USA · New York, USA · New York, NY, USA · Manhattan, New York, NY, USA · Soho, New York, NY, USA · Soho, New York, NY, USA
industry
Health · Hospital & Health Care
Size
11-50 employees
Stage
Other
founded in
2017
Embleema's software platform brings precision medicine sooner to patients by collecting and generating regulatory-grade evidence. Our platform natively unifies clinical, molecular, and real-world data and is the sole one used by the FDA for its regulatory evaluation of health products involving genomic datasets. The protocols and algorithms contained in our platform are also the basis for future CDISC standards for cell and gene therapies. The FDA also uses our platform to produce regulatory-grade genomic sequences for SARS-CoV-2 and other microbial pathogens (Project Argos). In addition to the FDA, our platform powers the Lupus Landmark Study, the largest clinical study for lupus in the world, the Human Epilepsy Projects, and tens of other clinical studies for pharmaceutical companies, biotechs, and patient groups. More than half of the top 10 investigational sites in the US use our platform: Johns Hopkins, NYU, UCSF, Yale, UPenn, Washington University in St. Louis, Cornell, and many others.
Is this your company?
Something looks off?
